Pitman Stuart K, Hoang Uyen T P, Wi Caren H, Alsheikh Mona, Hiner Dakota A, Percival Kelly M
College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
Department of Pharmaceutical Care, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.
Antibiotics (Basel). 2019 Jul 31;8(3):108. doi: 10.3390/antibiotics8030108.
Fluoroquinolones are a widely-prescribed, broad-spectrum class of antibiotics with several oral formulations notable for their high bioavailability. For certain infections, fluoroquinolones are the first line or only treatment choice. When administered orally, fluoroquinolones require proper administration to ensure adequate systemic absorption and, thereby, protect patients from treatment failure. Oral drug preparations that contain multivalent cations are well known to chelate with fluoroquinolones in the gastrointestinal tract; co-administration may lead to clinically significant decreases in oral fluoroquinolone bioavailability and an overall increase in fluoroquinolone-resistant bacteria. Based on a search and evaluation of the literature, this focused review describes oral fluoroquinolone-multivalent cation drug-drug interactions and their magnitude and offers several clinical management strategies for these potentially clinically significant interactions.
氟喹诺酮类是一类广泛应用的广谱抗生素,有多种口服制剂,其高生物利用度值得关注。对于某些感染,氟喹诺酮类是一线治疗药物或唯一的治疗选择。口服氟喹诺酮类药物时,需要正确给药以确保足够的全身吸收,从而防止患者治疗失败。众所周知,含有多价阳离子的口服药物制剂会在胃肠道中与氟喹诺酮类发生螯合作用;同时使用可能导致口服氟喹诺酮类药物的生物利用度出现临床显著下降,并使耐氟喹诺酮类细菌总体增加。基于对文献的检索和评估,本专题综述描述了口服氟喹诺酮类与多价阳离子之间的药物相互作用及其程度,并针对这些潜在的具有临床意义的相互作用提供了几种临床管理策略。